If patient cannot tolerate 2.4 mg dose, discontinue Saxenda
But our job doesn't end there
Additionally, with combination therapy as opposed to metformin, showed lower levels of fasting glucose, oral glucose tolerance test (OGTT) 2-h glucose, and OGTT 2-h insulin
research finds that most people who stop taking treatment typically regain at least some, if not all, of the weight lost and may lose blood sugar and other related benefits
Chronic bioenergetic failure, characterized by impaired oxidative phosphorylation and a persistent ATP deficit, may underlie the profound fatigue and PEM in ME/CFS
The association of GLP-1 with atherosclerosis in animals has been well established, proving anti-inflammatory effects of GLP-1 on atherosclerotic plaques by modulating inflammatory pathways and activity of macrophages